SELECTBIO is delighted to welcome you to its forthcoming International Conference “Emerging role of Next Generation Sequencing in Clinical Genomics” scheduled to be held on 01 November, 2017 at The Orchid in Mumbai,India.

Next-Generation Sequencing is transforming the way we used to diagnose several diseases. NGS has become a powerful tool in Genomics, Proteomics, Metabolomics, Transcriptomics as well as in Cross-Omics approaches. This conference brings together technology development with special emphasis on clinical applications of Next-Generation Sequencing (NGS). 

We also explore at this conference the translation of Next-Generation Sequencing (NGS) from research to deployment in the clinical-setting genetic testing including oncology and infectious disease. With increasing efficiency and decreasing cost, NGS has an opportunity and hope to be deployed as a means to personalize diagnostics and therapeutics. 

An exhibition covering the latest technologies in the field of “Next-Gen Sequencing in Clinical Genomics” will also be an added feature of the conference.  

We look forward to welcoming you at the “Emerging role of Next Generation Sequencing in Clinical Genomics” Conference and Exhibition and hope that the this one day will be both informative and enjoyable.

Delegate Profile - Director, Pathologists, Managers, Scientists, Lab Technologists and Resident Doctors from Diagnostics, Medical Devices, Pharmaceutical and Biotechnology Laboratories and Companies and Professors and Research Scholars from Academic Medical, Biotechnology and Pharmaceutical Institutions..

Sponsor Organizations - NGS Equipment and Consumable Suppliers, Diagnostic Equipment Manufacturers and Suppliers, Diagnostic Labs, Medical Devices Companies.

International Advisory Board Members

Dr. David Smith, Mayo Clinic , USA

Dr. Anthony Papenfuss,  Peter MacCallum Cancer Centre, Australia